Profile | About Trion Research
TRION Research is an independent research organization offering specialized diagnostic, preclinical and clinical services.
Originally founded in 1998 as an independent entity by Horst Lindhofer, we have assisted in the preclinical and clinical development of all Triomab® antibodies that are under development or received market approval, including that of Removab®, the first bispecific, trifunctional antibody on the market worldwide. We have also generated further candidates of the Triomab® family.
Over the years, we have gathered extensive experience in:
- Liquid Biopsy of various body fluids (blood, urine etc.)
- Tumor immunology and immunomonitoring
- Monitoring of virus-induced autoimmune disorders
- Data and sample management